Skip to main content

Table 3 Relative risk of 30-day mortality after colorectal cancer surgery in subgroups of patients with liver disease

From: Liver disease and 30-day mortality after colorectal cancer surgery: a Danish population-based cohort study

Subgroups

Patients N

No liver disease (reference cohort)

Non-cirrhotic liver disease Adjusted* RR (95%CI)

Liver cirrhosis Adjusted* RR (95%CI)

Gender:

    

- Male

20,390

1.00 (ref)

1.37 (0.88-2.13)

2.21 (1.20-4.01)

- Female

19,450

1.00 (ref)

1.56 (1.08-2.26)

2.82 (1.90-4.20)

Age at colorectal surgery (years):

    

- 0-59

7,160

1.00 (ref)

2.71 (1.25-5.89)

3.53 (1.53-8.13)

- 60-69

10,254

1.00 (ref)

1.56 (0.83-2.95)

3.61 (2.00-6.52)

- 70-79

13,332

1.00 (ref)

1.10 (0.65-1.87)

2.37 (1.40-4.02)

- 80+

9,094

1.00 (ref)

1.61 (1.01-2.56)

1.14 (0.36-3.59)

Timing of admission:

    

- Acute

12,829

1.00 (ref)

1.57 (1.11-2.22)

2.48 (1.59-3.88)

- Elective

26,932

1.00 (ref)

1.39 (0.85-2.28)

2.79 (1.70-4.57)

Cancer stage:

    

- Localized

17,272

1.00 (ref)

1.16 (0.65-2.06)

3.49 (2.06-5.93)

- Non-localized

19,121

1.00 (ref)

1.71 (1.20-2.43)

2.42 (1.49-3.94)

- Stage unknown

3,447

1.00 (ref)

1.41 (0.58-3.42)

2.24 (0.91-5.50)

Surgery:

    

- Laparoscopic radical resection

3,528

1.00 (ref)

NA

6.82 (1.48-31.45)

- Open radical resection

31,693

1.00 (ref)

1.41 (0.99-1.98)

3.01 (2.05-4.40)

- Non-resectional procedures

4,619

1.00 (ref)

1.91 (1.14-3.20)

1.74 (0.82-3.67)

Comorbidity level:

    

- Low

24,528

1.00 (ref)

1.62 (0.97-2.70)

3.41 (1.97-5.91)

- Moderate

11,783

1.00 (ref)

1.60 (1.07-2.41)

3.14 (1.91-5.16)

- High

3,529

1.00 (ref)

1.17 (0.62-2.19)

1.47 (0.68-3.15)

Non-hepatic alcohol-related disease †:

    

- Yes

682

1.00 (ref)

1.30 (0.94-1.81)

3.37 (2.30-4.92)

- No

39,158

1.00 (ref)

2.61 (1.43-4.76)

1.67 (0.88-3.10)

  1. RR, Relative Risk; CI, Confidence Interval; NA, Not Applicable.
  2. * Mutually adjusted for gender, age, timing of admission, cancer stage, surgery, comorbidity level, and non-hepatic alcohol-related disease.
  3. † Including both diagnoses of alcohol abuse and non-hepatic alcohol-related diseases.